Menarini Group and Insilico Medicine Forge Second Exclusive Global License for AI-Developed Preclinical Oncology Asset Addressing Unmet Medical Needs
The Menarini Group, in collaboration with Insilico Medicine, has made a significant advancement in oncology through their recent exclusive licensing agreement. Announced on January 10,...